Clinical Trials List
Protocol NumberZWI-ZW25-203
Completed
2021-12-01 - 2024-12-31
Phase II
Recruiting2
ICD-10C24.9
Malignant neoplasm of biliary tract, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9156.9
Malignant neoplasm of biliary tract, part unspecified
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- San-Chi Chen Division of Hematology & Oncology
- I-Cheng Lee Digestive System Department
- Rheun-Chuan Lee Division of Pediatrics
- Pei-Chang Lee Division of General Internal Medicine
- Yee Chao Division of Hematology & Oncology
- Chien-An Liu Division of Radiology
- Yi-Ping Hung Division of Hematology & Oncology
- Chung-Pin Li Digestive System Department
- 黃宣恩 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Meng-Jer Hsieh Division of Hematology & Oncology
- 裴松南 Division of Hematology & Oncology
- 蔡郁棻 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
100 participants
